Chemokines and Chemokine Receptors in susceptibility to HIV-1 infection and progression to AIDS

Disease Markers

Volumn 32, Issue 3, 2012, Pages 143-151

  Chatterjee, Animesh ^a   Rathore, Anurag ^a   Vidyant, Sanjukta ^a   Kakkar, Kavita ^a   Dhole, Tapan N ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemokine receptor; Chemokines; HIV 1 infection; Polymorphism

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CD4 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CX3C CHEMOKINE; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; STROMAL CELL DERIVED FACTOR 1; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RESTRICTION GENE; COPY NUMBER VARIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VIRUS PATHOGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84858261787     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0874     Document Type: Review

References (92)

1. UNAIDS 2008. 2008 AIDS epidemic update. http://www. unaids.org/en/.
2. NACO (2008). HIV/AIDS epidemiological Surveillance and Estimation report for the year 2008.
3. W.C. Goh, J. Markee, R.E. Akridge, M. Meldorf, L. Musey, T. Karchmer, M. Krone, A. Collier, L. Corey, M. Emerman and M.J. McElrath, Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects, J Infect Dis 179(3) (1999), 548-557. (Pubitemid 30016137)
4. F.A. Plummer, T.B. Ball, J. Kimani and K.R. Fowke, Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol Lett 66(1-3) (1999), 27-34. (Pubitemid 29136815)
5. S. Mazzoli, D. Trabattoni, S. Lo Caputo, S. Piconi, C. Blé, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, M.L. Fusi, N. Tofani, M. Biasin, M.L. Villa, F. Mazzotta and M. Clerici, HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals, Nat Med 3(11) (1997), 1250-1257. (Pubitemid 27508826)
6. E. Pisani, AIDS into the 21st century: some critical considerations, Reprod Health Matters 8(15) (2000), 63-76. (Pubitemid 30352894)
7. R. Detels, Z. Liu, K. Hennessey, J. Kan, B.R. Visscher, J.M. Taylor, D.R. Hoover, C.R. Rinaldo, Jr., J.P. Phair, A.J. Saah et al., Resistance to HIV-1 infection. Multicenter AIDS Cohort Study, J Acquir Immune Defic Syndr 7(12) (1994), 1263-1269.
8. J. Phair, L. Jacobson, R. Detels, C. Rinaldo, A. Saah, L. Schrager and A. Mum̃ oz, Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study, J Acquir Immune Defic Syndr 5(5) (1992), 490-496.
9. Y. Cao, L. Qin, L. Zhang, J. Safrit and D.D. Ho, Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection, N Engl J Med 332(4) (1995), 201-208.
10. G. Pantaleo, S. Menzo, M. Vaccarezza, C. Graziosi, O.J. Cohen, J.F. Demarest, D. Montefiori, J.M. Orenstein, C. Fox, L.K. Schrager et al., Studies in subjects with long-term non-progressive human immunodeficiency virus infection, N Engl J Med 332(4) (1995), 209-216.
11. S.P. Buchbinder, M.H. Katz, N.A. Hessol, P.M. O'Malley and S.D. Holmberg, Long-term HIV-1 infection without immuno-logic progression, AIDS 8(8) (1994), 1123-1128. (Pubitemid 24228710)
12. H. Liu, Y. Hwangbo, S. Holte, J. Lee, C. Wang, N. Kaupp, H. Zhu, C. Celum, L. Corey, M.J. McElrath and T. Zhu, Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seroneg-ative individuals repeatedly exposed to HIV-1, J Infect Dis 190(6) (2004), 1055-1058. (Pubitemid 39186790)
13. F. Hladik, A. Desbien, J. Lang, L. Wang, Y. Ding, S. Holte, A. Wilson, Y. Xu, M. Moerbe, S. Schmechel and M.J. McEl-rath, Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells, J Immunol 171(5) (2003), 2671-2683. (Pubitemid 37025581)
14. S.C. Schmechel, N. Russell, F. Hladik, J. Lang, A. Wilson, R. Ha, A. Desbien and M.J. McElrath, Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons, Immunol Lett 79(1-2) (2001), 21-27. (Pubitemid 32938204)
15. R. Akridge, F. Hladik, J. Markee, C. Alef, H. Kelley, A. Collier, A. Collier and M.J. McElrath, Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure, Immunol Lett 66(1-3) (1999), 15-19. (Pubitemid 29136813)
16. E. Gonzalez, H. Kulkarni, H. Bolivar, A. Mangano, R. Sanchez, G. Catano, R.J. Nibbs, B.I. Freedman, M.P. Quin-ones, M.J. Bamshad, K.K. Murthy, B.H. Rovin, W. Bradley, R.A. Clark, S.A. Anderson, R.J. O'connell, B.K. Agan, S.S. Ahuja, R. Bologna, L. Sen, M.J. Dolan and S.K. Ahuja, The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility, Science 307(5714) (2005), 1434-1440. (Pubitemid 40321934)
17. S.J. O'Brien and G.W. Nelson, Human genes that limit AIDS, Nat Genet 36(6) (2004), 565-574. (Pubitemid 38715980)
18. W.A. Paxton, T. Dragic, R.A. Koup and J.P. Moore, The beta-chemokines, HIV type 1-second receptors, and exposed un-infected persons, AIDS Res Hum Retroviruses 12(13) (1996), 1203-1207.
19. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vit-tinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels and S.J. O'Brien, Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multi-center Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, Science 273(5283) (1996), 1856-1862.
20. P. Suresh and A. Wanchu, Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics, J Postgrad Med 52(3) (2006), 210-217. (Pubitemid 44154525)
21. A. Zlotnik and O. Yoshie, Chemokines: a new classification system and their role in immunity, Immunity 12(2) (2000), 121-127. (Pubitemid 30398626)
22. I.F. Charo and R.M. Ransohoff, The many roles of chemokines and chemokine receptors in inflammation, N Engl J Med 354(6) (2006), 610-621. (Pubitemid 43209108)
23. G. Alkhatib, C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy and E.A. Berger, CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofac-tor for macrophage-tropic HIV-1, Science 272(5270) (1996), 1955-1958. (Pubitemid 26234510)
24. H. Choe, M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard and J. Sodroski, The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates, Cell 85(7) (1996), 1135-1148. (Pubitemid 26231178)
25. B.J. Doranz, J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman and R.W. Doms, A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors, Cell 85(7) (1996), 1149-1158. (Pubitemid 26235280)
26. M.P. Martin, M. Dean, M.W. Smith, C. Winkler, B. Gerrard, N.L. Michael, B. Lee, R.W. Doms, J. Margolick, S. Buch-binder, J.J. Goedert, T.R. O'Brien, M.W. Hilgartner, D. Vla-hov, S.J. O'Brien and M. Carrington, Genetic acceleration of AIDS progression by a promoter variant of CCR5, Science 282(5395) (1998), 1907-1911. (Pubitemid 28555273)
27. D.H. McDermott, P.A. Zimmerman, F. Guignard, C.A. Klee-berger, S.F. Leitman and P.M. Murphy, CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS), Lancet 352(9131) (1998), 866-870. (Pubitemid 28416720)
28. M.W. Smith, M. Dean, M. Carrington, C. Winkler, G.A. Hutt-ley, D.A. Lomb, J.J. Goedert, T.R. O'Brien, L.P. Jacobson, R. Kaslow, S. Buchbinder, E. Vittinghoff, D. Vlahov, K. Hoots, M.W. Hilgartner and S.J. O'Brien, Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicen-ter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study, Science 277(5328) (1997), 959-965.
29. R. Liu, W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk et al., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection, Cell 86(3) (1996), 367-77. (Pubitemid 26272077)
30. M. Samson, F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R.J. Smyth, R.G. Collman, R.W. Doms, G. Vassart and M. Parmentier, Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, Nature 382(6593) (1996), 722-725.
31. J. Schinkel, M.W. Langendam, R.A. Coutinho, A. Krol, M. Brouwer and H. Schuitemaker, No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users, J Infect Dis 179(4) (1999), 825-831. (Pubitemid 29159327)
32. G.J. Stewart, L.J. Ashton, R.A. Biti, R.A. Ffrench, B.H. Bennetts, N.R. Newcombe, E.M. Benson, A. Carr, D.A. Cooper and J.M. Kaldor, Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group, AIDS 11(15) (1997), 1833-1838. (Pubitemid 27500959)
33. N.L. Michael, L.G. Louie and H.W. Sheppard, CCR5-delta 32 gene deletion in HIV-1 infected patients, Lancet 350(9079) (1997), 741-742.
34. R.A. Morawetz, G.P. Rizzardi, D. Glauser, O. Rutschmann, B. Hirschel, L. Perrin, M. Opravil, M. Flepp, J. von Overbeck, M.P. Glauser, S. Ghezzi, E. Vicenzi, G. Poli, A. Lazzarin and G. Pantaleo, Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort, Eur J Immunol 27(12) (1997), 3223-3227. (Pubitemid 28018018)
35. Q. Jin, J. Marsh, K. Cornetta and G. Alkhatib, Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5 {Delta} 32 gene despite detectable expression of the HIV-1 co-receptors, J Gen Virol 89 (2008), 2611-2621.
36. L. Agrawal, Q. Jin, J. Altenburg, L. Meyer, R. Tubiana, I. Theodorou and G. Alkhatib, CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo, J Virol 81(15) (2007), 8041-8049. (Pubitemid 47101490)
37. V. Alvarez, C. López-Larrea and E. Coto, Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users, Hum Genet 102(4) (1998), 483-486. (Pubitemid 28203994)
38. G.V. Ramana, A. Vasanthi, M. Khaja, B. Su, V. Govindaiah, L. Jin, L. Singh and R. Chakraborty, Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India, J Genet 80(3) (2001), 137-140. (Pubitemid 33572487)
39. A. Voevodin, E. Samilchuk and S. Dashti, Frequencies of SDF-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis, J Med Virol 58(1) (1999), 54-58. (Pubitemid 29172121)
40. A.O. Clegg, L.J. Ashton, R.A. Biti, P. Badhwar, P. Williamson, J.M. Kaldor and G.J. Stewart, CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group, AIDS 14(2) (2000), 103-108. (Pubitemid 30116434)
41. T.B. Knudsen, T.B. Kristiansen, T.L. Katzenstein and J. Eugen-Olsen, Adverse effect of the CCR5 promoter-2459A allele on HIV-1 disease progression, J Med Virol 65(3) (2001), 441-444. (Pubitemid 32959066)
42. P. An, M.P. Martin, G.W. Nelson, M. Carrington, M.W. Smith, K. Gong, D. Vlahov, S.J. O'Brien and C.A. Winkler, Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans, AIDS 14(14) (2000), 2117-2122.
43. A. Rathore, A. Chatterjee, P. Sivarama, N. Yamamoto, P.K. Singhal and T.N. Dhole, Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians, AIDS Res Hum Retroviruses 25(11) (2009), 1149-1156.
44. P.J. Easterbrook, T. Rostron, N. Ives, M. Troop, B.G. Gazzard and S.L. Rowland-Jones, Chemokine receptor polymorphisms and human immunodeficiency virus disease progression, J Infect Dis 180(4) (1999), 1096-1105. (Pubitemid 30070192)
45. G. Kaur, P. Singh, C.C. Rapthap, N. Kumar, M. Vajpayee, S.K. Sharma, A. Wanchu and N.K. Mehra, Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians, Hum Immunol 68(5) (2007), 454-461. (Pubitemid 46616972)
46. T.J. Wasik, J. Smoleń, P. Kruszyński, J. Bratosiewicz-Wasik and M. Beniowski, Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population, Wi a d L e k 58(9-10) (2005), 500-507.
47. F. Roman, N. Franck, C. Burgy, J. Servais, J.M. Zimmer, J. Mossong, P. Goubau, F. Schneider, R. Hemmer and J.C. Schmit, Prevalence of HIV co-receptor polymorphisms in HIV-infected patients and uninfected volunteers in Luxembourg, HIV Clin Trials 3(3) (2002), 195-201. (Pubitemid 34704867)
48. G.C. John, T. Bird, J. Overbaugh, R. Nduati, D. Mbori-Ngacha, T. Rostron, T. Dong, L. Kostrikis, B. Richardson and S.L. Rowland-Jones, CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality, J Infect Dis 184(1) (2001), 89-92. (Pubitemid 32568505)
49. S.G. Irving, P.F. Zipfel, J. Balke, O.W. McBride, C.C. Morton, P.R. Burd, U. Siebenlist and K. Kelly, Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q, Nucleic Acids Res 18(11) (1990), 3261-3270.
50. P. Menten, A. Wuyts and J. Van Damme, Macrophage inflammatory protein-1, Cytokine Growth Factor Rev 13(6) (2002), 455-481. (Pubitemid 35303816)
51. T. Nakajima, H. Ohtani, T. Naruse, H. Shibata, J.I. Mimaya, H. Terunuma and A. Kimura, Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia, Immunogenetics 59(10) (2007), 793-798; Nat Med 4(3) (1998), 350-353.
52. W. Shao, J. Tang, W. Song, C. Wang, Y. Li, C.M. Wilson and R.A. Kaslow, CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection, Genes Immun 8(3) (2007), 224-231. (Pubitemid 46672055)
53. J.R. Townson, L.F. Barcellos and R.J. Nibbs, Gene copy number regulates the production of the human chemokine CCL3-L1, Eur J Immunol 32(10) (2002), 3016-3026. (Pubitemid 35238195)
54. E. Pilotti, L. Elviri, E. Vicenzi, U. Bertazzoni, M.C. Re, S. Allibardi, G. Poli and C. Casoli, Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication, Blood 109(5) (2007), 1850-1856. (Pubitemid 46348179)
55. H. Moriuchi, M. Moriuchi and A.S. Fauci, Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection, J Immunol 158(7) (1997), 3483-3491. (Pubitemid 127484070)
56. F. Cocchi, A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo and P. Lusso, Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells, Science 270(5243) (1995), 1811-1815.
57. F. Arenzana-Seisdedos, J.L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, B. Moser and M. Baggiolini, HIV blocked by chemokine antagonist, Nature 383(6599) (1996), 400. (Pubitemid 26330820)
58. M. Mack, B. Luckow, P.J. Nelson, J. Cihak, G. Simmons, P.R. Clapham, N. Signoret, M. Marsh, M. Stangassinger, F. Borlat, T.N. Wells, D. Schlöndorff and A.E. Proudfoot, Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity, J Exp Med 187(8) (1998), 1215-1224. (Pubitemid 28189111)
59. P. An, G.W. Nelson, L. Wang, S. Donfield, J.J. Goedert, J. Phair, D. Vlahov, S. Buchbinder, W.L. Farrar, W. Modi, S.J. O'Brien and C.A. Winkler, Modulating influence on HIV/AIDS by interacting RANTES gene variants, Proc Natl Acad Sci USA 99(15) (2002), 10002-10007. (Pubitemid 34831162)
60. H. Liu, D. Chao, E.E. Nakayama, H. Taguchi, M. Goto, X. Xin, J.K. Takamatsu, H. Saito, Y. Ishikawa, T. Akaza, T. Juji, Y. Takebe, T. Ohishi, K. Fukutake, Y. Maruyama, S. Yashiki, S. Sonoda, T. Nakamura, Y. Nagai, A. Iwamoto and T. Shioda, Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression, Proc Natl Acad Sci USA 96(8) (1999), 4581-4585. (Pubitemid 29190379)
61. R.G. Nickel, V. Casolaro, U. Wahn, K. Beyer, K.C. Barnes, B.S. Plunkett, L.R. Freidhoff, C. Sengler, J.R. Plitt, R.P. Schleimer, L. Caraballo, R.P. Naidu, P.N. Levett, T.H. Beaty and S.K. Huang, Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES, J Immunol 164(3) (2000), 1612-1616. (Pubitemid 30067281)
62. A. Rathore, A. Chatterjee, P. Sivarama, N. Yamamoto, P.K. Singhal and T.N. Dhole, Association of RANTES-403 G/A,-28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians, J Med Virol 80(7) (2008), 1133-1141. (Pubitemid 351705991)
63. P. Suresh, A. Wanchu, R.K. Sachdeva and A. Bhatnagar, Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India, J Clin Immunol 26(5) (2006), 476-484. (Pubitemid 44440181)
64. F. Vidal, J. Peraire, P. Domingo, M. Broch, M. Cairó, E. Pedrol, M. Montero, C. Viladés, C. Gutiérrez, M.A. Sam-beat, A. Fontanet, D. Dalmau, E. Deig, H. Knobel, J.J. Sir-vent, C. Richart, S. Veloso, M. Saumoy, M. López-Dupla, M. Olona, J. Cadafalch, M. Fuster, A. Ochoa, A. Soler, A. Guelar and J. Gonzälez, Chemokines and Long-Term Nonprogressive HIV01 Infection Study Group. Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 years, J Ac-quir Immune Defic Syndr 41(1) (2006), 17-22. (Pubitemid 41786014)
65. D.H. McDermott, M.J. Beecroft, C.A. Kleeberger, F.M. Al-Sharif, W.E. Ollier, P.A. Zimmerman, B.A. Boatin, S.F. Leitman, R. Detels, A.H. Hajeer and P.M. Murphy, Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study, AIDS 14(17) (2000), 2671-2678. (Pubitemid 32118720)
66. X.Y. Zhao, S.S. Lee, K.H. Wong, K.C. Chan, S. Ma, W.C. Yam, K.Y. Yuen, M.H. Ng and B.J. Zheng, Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese, Eur J Immunogenet 31(4) (2004), 179-183. (Pubitemid 39049863)
67. G.S. Cooke, K. Tosh, P.A. Ramaley, P. Kaleebu, J. Zhuang, J.S. Nakiyingi, C. Watera, C.F. Gilks, N. French, J.A. Whit-worth and A.V. Hill, A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease, J Infect Dis 194(5) (2006), 666-669. (Pubitemid 44297853)
68. L.G. Kostrikis, Y. Huang, J.P. Moore, S.M. Wolinsky, L. Zhang, Y. Guo, L. Deutsch, J. Phair, A.U. Neumann and D.D. Ho, A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
69. G. Kaur, P. Singh, N. Kumar, C.C. Rapthap, G. Sharma, M. Vajpayee, N. Wig, S.K. Sharma and N.K. Mehra, Distribution of CCR2 polymorphism in HIV-1-infected and healthy subjects in North India, Int J Immunogenet 34(3) (2007), 153-156. (Pubitemid 46763547)
70. M. Carrington, G. Nelson and S.J. O'Brien, Considering genetic profiles in functional studies of immune responsiveness to HIV-1, Immunol Lett 79(1-2) (2001), 131-140. (Pubitemid 32938218)
71. S. Louisirirotchanakul, H. Liu, A. Roongpisuthipong, E.E. Nakayama, Y. Takebe, T. Shioda and C. Wasi, Genetic analysis of HIV-1 discordant couples in Thailand: association of CCR2 64I homozygosity with HIV-1-negative status, J Acquir Immune Defic Syndr 29(3) (2002), 314-315. (Pubitemid 34208542)
72. O.J. Cohen, S. Paolucci, S.M. Bende, M. Daucher, H. Mori-uchi, M. Moriuchi, C. Cicala, R.T. Davey, Jr., B. Baird and A.S. Fauci, CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Delta32, J Virol 72(7) (1998), 6215-6217. (Pubitemid 28283418)
73. D.C. Petersen, R.H. Glashoff, S. Shrestha, J. Bergeron, A. Laten, B. Gold, E.J. van Rensburg, M. Dean and V.M. Hayes, Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population, J Acquir Immune Defic Syndr 40(5) (2005), 521-526. (Pubitemid 41669154)
74. C.C. Bleul, M. Farzan, H. Choe et al., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry, Nature 382 (1996), 829-833. (Pubitemid 26299570)
75. E. Oberlin, A. Amara, F. Bachelerie et al., The CXC ch-emokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1, Nature 382 (1996), 833-835. (Pubitemid 26299571)
76. A. Amara, S.L. Gall, O. Schwartz et al., HIV coreceptor down-regulation as antiviral principle: SDF-1 alpha-dependent in-ternalisation of the chemokine receptor CXCR4 contributes to inhibition of HIV replication, J Exp Med 186 (1997), 139-146. (Pubitemid 27304856)
77. N. Signoret, J. Oldridge, A. Pelchen-Matthews et al., Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4, J Cell Biol 139 (1997), 651-664. (Pubitemid 27485831)
78. C. Winkler, W. Modi, M.W. Smith, G.W. Nelson, X. Wu, M. Carrington, M. Dean et al., Genetic restriction of AIDS patho-genesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multi-center AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Science 279(5349) (1998), 389-393.
79. H. Hendel, N. Hénon, H. Lebuanec, A. Lachgar, H. Poncelet, S. Caillat-Zucman, C.A. Winkler, M.W. Smith, L. Kenefic, S. O'Brien, W. Lu, J.M. Andrieu, D. Zagury, F. Schächter, J. Rappaport and J.F. Zagury, Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression, J Acquir Immune Defic Syndr 19(4) (1998), 381-386. (Pubitemid 28536047)
80. N. Ramamoorti, J. Kumarvelu, G.K. Shanmugasundaram, K. Rani and A.C. Banerjea, High frequency of G to A transition mutation in the stromal cell derived factor-1 gene in India, a chemokine that blocks HIV-1 (X4) infection: multiple proteins bind to 3'-untranslated region of SDF-1 RNA, Genes Immun 2(7) (2001), 408-410. (Pubitemid 33674258)
81. M. Matloubian, A. David, S. Engel, J.E. Ryan and J.G. Cys-ter, A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo, Nat Immunol 1 (2000), 298-304.
82. H.K. Deng, D. Unutmaz, V.N. Kewalramani and D.R. Littman, Expression cloning of new receptors used by simian and human immunodeficiency viruses, Nature 388 (1997), 296-300. (Pubitemid 27317976)
83. F. Liao, G. Alkhatib, K.W. Peden et al., STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1, J Exp Med 185 (1997), 2015-2023. (Pubitemid 27247087)
84. M. Loetscher, A. Amara, E. Oberlin et al., TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function, Curr Biol 7 (1997), 652-660. (Pubitemid 27408863)
85. P. Duggal, P. An, T.H. Beaty, S.A. Strathdee, H. Farzadegan, R.B. Markham, L. Johnson, S.J. O'Brien, D. Vlahov and C.A. Winkler, Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans, Genes Immun 4 (2003), 245-250. (Pubitemid 39562122)
86. S. Limou, C. Coulonges, J.T. Herbeck, D. van Manen et al., Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS, J Infect Dis 202(6) (2010), 908-915.
87. S. Faure, L. Meyer, D. Costagliola, C. Vaneensberghe, E. Genin, B. Autran, J.F. Delfraissy, D.H. McDermott, P.M. Murphy, P. Debré, I. Théodorou and C. Combadière, Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1, Science 287(5461) (2000), 2274-2277. (Pubitemid 30177034)
88. S. Faure, L. Meyer, E. Genin, P. Pellet, P. Debré, I. Théodorou and C. Combadière, SEROCO Study Group. Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression, J Acquir Immune Defic Syndr 32(3) (2003), 335-337. (Pubitemid 36331707)
89. D.H. McDermott, J.S. Colla, C.A. Kleeberger, M. Plankey, P.S. Rosenberg, E.D. Smith, P.A. Zimmerman, C. Combadière, S.F. Leitman, R.A. Kaslow, J.J. Goedert, E.A. Berger, T.R. O'Brien and P.M. Murphy, Genetic polymorphism in CX3CR1 and risk of HIV disease, Science 290(5499) (2000), 2031.
90. D. Kwa, B. Boeser-Nunnink and H. Schuitemaker, Lack of evidence for an association between a polymorphism in CX3CR1 and the clinical course of HIVinfection or virus phenotype evolution, AIDS 17(5) (2003), 759-761. (Pubitemid 36521085)
91. F. Vidal, C. Viladés, P. Domingo, M. Broch, E. Pedrol, D. Dalmau, H. Knobel, J. Peraire, C. Gutiérrez, M.A. Sambeat, A. Fontanet, E. Deig, M. Cairó, M. Montero, C. Richart and S. Mallal, Chemokines LTNP Study Group. Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele, J Acquir Immune Defic Syndr 40(5) (2005), 527-531. (Pubitemid 41669155)
92. K.K. Singh, M.D. Hughes, J. Chen and S.A. Spector, Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load, J Infect Dis 191(11) (2005), 1971-1980. (Pubitemid 40705406)